Precision BioSciences Inc (DTIL) bonds
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)
Close on Nov 18, 2026Market cap $195.97MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Precision BioSciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Precision BioSciences's 10-Q for the period ended Jun 30, 2026
Precision BioSciences's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| 2024 Term Loan | $22.50M |
| Loan and Security Agreement | – |
See a number that looks wrong?